Bcl-xl was detected in all tumors tested and more intense immunostaining was observed in the high grade primary tumors and in metastases compared to prostatic intraepithelial neoplasia (PIN) and low grade neoplasms (P < 0.0001). Here, BCL2L1 is linked to prostate intraepithelial neoplasia.